Dynasil (DYSL) Cash Flow Statement

Click line-items for a historical chart and %

Cash flows from operating activities:
Net income
Adjustments to reconcile net income to net cash provided by operating activities
Stock compensation expense	592K
Provision for doubtful accounts and sales returns
Depreciation and amortization	939K
Deferred income taxes
Net increase (decrease) in billings in excess of costs	268K
(Increase) decrease in:
Accounts receivable	-1.76M
Inventories	-1.09M
Prepaid income taxes
Prepaid expenses and other current assets	-92K
Increase (decrease) in:
Accounts payable and accrued expenses
Income taxes payable
Net cash provided by operating activities
Cash flows from investing activities:
Purchases of property, plant and equipment	-1.34M
Acquisition of Biomedical technologies
Decrease in other assets
Net cash used in investing activities
Cash flows from financing activities
Issuance of common stock	11K
Repayment of long term debt	-740K
Preferred stock dividends paid
Net cash used in financing activities
Effect of exchange rates on cash and cash equivalents	-81K
Net increase in cash and cash equivalents	-1.06M
Cash and cash equivalents, beginning	1.3M
Cash and cash equivalents, ending	232K

Entities mentioned with DYSL